Nivolumab plus Ipilimumab in Advanced Melanoma von WOLCHOK, Jedd D, KLUGER, Harriet, BURKE, Matthew M, CALDWELL, Anne, KRONENBERG, Stephanie A, AGUNWAMBA, Blessing U, XIAOLING ZHANG, LOWY, Israel, INZUNZA, Hector David, FEELY, William, HORAK, Christine E, QUAN HONG, CALLAHAN, Margaret K, KORMAN, Alan J, WIGGINTON, Jon M, GUPTA, Ashok, SZNOL, Mario, POSTOW, Michael A, RIZVI, Naiyer A, LESOKHIN, Alexander M, SEGAL, Neil H, ARIYAN, Charlotte E, GORDON, Ruth-Ann, REED, Kathleen

Volltext

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab von TOPALIAN, Suzanne L, SZNOL, Mario, LEMING, Philip D, LIPSON, Evan J, PUZANOV, Igor, SMITH, David C, TAUBE, Janis M, WIGGINTON, Jon M, KOLLIA, Georgia D, GUPTA, Ashok, PARDOLL, Drew M, SOSMAN, Jeffrey A, McDERMOTT, David F, STEPHEN HODI, F, KLUGER, Harriet M, CARVAJAL, Richard D, SHARFMAN, William H, BRAHMER, Julie R, LAWRENCE, Donald P, ATKINS, Michael B, POWDERLY, John D

Volltext

Nivolumab plus Ipilimumab in Advanced Melanoma von Wolchok, Jedd D, Kluger, Harriet, Callahan, Margaret K, Postow, Michael A, Rizvi, Naiyer A, Lesokhin, Alexander M, Segal, Neil H, Ariyan, Charlotte E, Gordon, Ruth-Ann, Reed, Kathleen, Burke, Matthew M, Caldwell, Anne, Kronenberg, Stephanie A, Agunwamba, Blessing U, Zhang, Xiaoling, Lowy, Israel, Inzunza, Hector David, Feely, William, Horak, Christine E, Hong, Quan, Korman, Alan J, Wigginton, Jon M, Gupta, Ashok, Sznol, Mario

Volltext

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer von Gettinger, Scott N, Horn, Leora, Gandhi, Leena, Spigel, David R, Antonia, Scott J, Rizvi, Naiyer A, Powderly, John D, Heist, Rebecca S, Carvajal, Richard D, Jackman, David M, Sequist, Lecia V, Smith, David C, Leming, Philip, Carbone, David P, Pinder-Schenck, Mary C, Topalian, Suzanne L, Hodi, F Stephen, Sosman, Jeffrey A, Sznol, Mario, McDermott, David F, Pardoll, Drew M, Sankar, Vindira, Ahlers, Christoph M, Salvati, Mark, Wigginton, Jon M, Hellmann, Matthew D, Kollia, Georgia D, Gupta, Ashok K, Brahmer, Julie R

Volltext

Combination immunotherapy: a road map von Ott, Patrick A, Hodi, F Stephen, Kaufman, Howard L, Wigginton, Jon M, Wolchok, Jedd D

Volltext

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab von McDermott, David F, Drake, Charles G, Sznol, Mario, Choueiri, Toni K, Powderly, John D, Smith, David C, Brahmer, Julie R, Carvajal, Richard D, Hammers, Hans J, Puzanov, Igor, Hodi, F Stephen, Kluger, Harriet M, Topalian, Suzanne L, Pardoll, Drew M, Wigginton, Jon M, Kollia, Georgia D, Gupta, Ashok, McDonald, Dan, Sankar, Vindira, Sosman, Jeffrey A, Atkins, Michael B

Volltext

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer von Brahmer, Julie R, Tykodi, Scott S, Chow, Laura Q.M, Hwu, Wen-Jen, Topalian, Suzanne L, Hwu, Patrick, Drake, Charles G, Camacho, Luis H, Kauh, John, Odunsi, Kunle, Pitot, Henry C, Hamid, Omid, Bhatia, Shailender, Martins, Renato, Eaton, Keith, Chen, Shuming, Salay, Theresa M, Alaparthy, Suresh, Grosso, Joseph F, Korman, Alan J, Parker, Susan M, Agrawal, Shruti, Goldberg, Stacie M, Pardoll, Drew M, Gupta, Ashok, Wigginton, Jon M

Volltext

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response von Arnaldez, Fernanda I, O'Day, Steven J, Drake, Charles G, Fox, Bernard A, Fu, Bingqing, Urba, Walter J, Montesarchio, Vincenzo, Weber, Jeffrey S, Wei, Haiming, Wigginton, Jon M, Ascierto, Paolo Antonio

Volltext

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab von Topalian, Suzanne L, Sznol, Mario, McDermott, David F, Kluger, Harriet M, Carvajal, Richard D, Sharfman, William H, Brahmer, Julie R, Lawrence, Donald P, Atkins, Michael B, Powderly, John D, Leming, Philip D, Lipson, Evan J, Puzanov, Igor, Smith, David C, Taube, Janis M, Wigginton, Jon M, Kollia, Georgia D, Gupta, Ashok, Pardoll, Drew M, Sosman, Jeffrey A, Hodi, F Stephen

Volltext

Immunotherapy of cancer by IL-12-based cytokine combinations von Weiss, Jonathan M, Subleski, Jeff J, Wigginton, Jon M, Wiltrout, Robert H

Volltext

Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages von Buhtoiarov, Ilia N, Sondel, Paul M, Wigginton, Jon M, Buhtoiarova, Tatiana N, Yanke, Eric M, Mahvi, David A, Rakhmilevich, Alexander L

Volltext

Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor von CALLAHAN, Margaret K, MASTERS, Gregg, GUPTA, Ashok, WIGGINTON, Jon M, ROSEN, Neal, MERGHOUB, Taha, JURE-KUNKEL, Maria, WOLCHOK, Jedd D, PRATILAS, Christine A, ARIYAN, Charlotte, KATZ, Jessica, KITANO, Shigehisa, RUSSELL, Valerie, GORDON, Ruth Ann, VYAS, Shachi, YUAN, Jianda

Volltext

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy von Gnjatic, Sacha, Bronte, Vincenzo, Brunet, Laura Rosa, Butler, Marcus O, Disis, Mary L, Galon, Jérôme, Hakansson, Leif G, Hanks, Brent A, Karanikas, Vaios, Khleif, Samir N, Kirkwood, John M, Miller, Lance D, Schendel, Dolores J, Tanneau, Isabelle, Wigginton, Jon M, Butterfield, Lisa H

Volltext

IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells von Salcedo, Rosalba, Stauffer, Jimmy K, Lincoln, Erin, Back, Timothy C, Hixon, Julie A, Hahn, Cynthia, Shafer-Weaver, Kimberly, Malyguine, Anatoli, Kastelein, Robert, Wigginton, Jon M

Volltext

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Meta... von Salcedo, Rosalba, Hixon, Julie A, Stauffer, Jimmy K, Jalah, Rashmi, Brooks, Alan D, Khan, Tahira, Dai, Ren-Ming, Scheetz, Loretta, Lincoln, Erin, Back, Timothy C, Powell, Douglas, Hurwitz, Arthur A, Sayers, Thomas J, Kastelein, Robert, Pavlakis, George N, Felber, Barbara K, Trinchieri, Giorgio, Wigginton, Jon M

Volltext

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers" von Butterfield, Lisa H, Disis, Mary L, Fox, Bernard A, Lee, Peter P, Khleif, Samir N, Thurin, Magdalena, Trinchieri, Giorgio, Wang, Ena, Wigginton, Jon, Chaussabel, Damien, Coukos, George, Dhodapkar, Madhav, Håkansson, Leif, Janetzki, Sylvia, Kleen, Thomas O, Kirkwood, John M, Maccalli, Cristina, Maecker, Holden, Maio, Michele, Malyguine, Anatoli, Masucci, Giuseppe, Palucka, A Karolina, Potter, Douglas M, Ribas, Antoni, Rivoltini, Licia, Schendel, Dolores, Seliger, Barbara, Selvan, Senthamil, Slingluff, Jr, Craig L, Stroncek, David F, Streicher, Howard, Wu, Xifeng, Zeskind, Benjamin, Zhao, Yingdong, Zocca, Mai-Britt, Zwierzina, Heinz, Marincola, Francesco M

Volltext

The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting von Kaufman, Howard L., Atkins, Michael B., Dicker, Adam P., Jim, Heather S., Garrison, Louis P., Herbst, Roy S., McGivney, William T., Silverstein, Steven, Wigginton, Jon M., Yu, Peter P.

Volltext

Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors von Khan, Tahira, Stauffer, Jimmy K, Williams, Rebecca, Hixon, Julie A, Salcedo, Rosalba, Lincoln, Erin, Back, Timothy C, Powell, Douglas, Lockett, Stephen, Arnold, Alma C, Sayers, Thomas J, Wigginton, Jon M

Volltext

Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses von Murphy, William J, Welniak, Lisbeth, Back, Timothy, Hixon, Julie, Subleski, Jeff, Seki, Naoko, Wigginton, Jon M, Wilson, Susan E, Blazar, Bruce R, Malyguine, Anatoli M, Sayers, Thomas J, Wiltrout, Robert H

Volltext

Administration of Interleukin 12 With Pulse Interleukin 2 and the Rapid and Complete Eradication of Murine Renal Carcinoma von Wigginton, Jon M., Komschlies, Kristin L., Back, Timothy C., Franco, José L., Brunda, Michael J., Wiltrout, Robert H.

Volltext